Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA® Apr 01, 2021
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular Acne Mar 22, 2021
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights Mar 09, 2021
Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference Mar 04, 2021
Caelum Biosciences Announces Collaborations with the Amyloidosis Advocacy Community and Support of Amyloidosis Awareness Month Mar 01, 2021